Polysomnographic findings during non-continuous administration of zolpidem

Sleep Medicine Reviews

Volumn 6, Issue SUPPL. 1, 2002, Pages

  Cluydts, Raymond ^a   Heyde, Karin ^b   De Volder, Ilse ^b  

^a FREE UNIVERSITY OF BRUSSELS   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Chronic insomnia; Discontinuous treatment; EEG; Polysomnography; Rebound; Zolpidem

Indexed keywords

BENZODIAZEPINE DERIVATIVE; HYPNOTIC AGENT; PLACEBO; ZOLPIDEM;

CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG INTERMITTENT THERAPY; HOME; HUMAN; INSOMNIA; LABORATORY; LATENT PERIOD; POLYSOMNOGRAPHY; REM SLEEP; SINGLE BLIND PROCEDURE; SLEEP TIME;

EID: 0036797328     PISSN: 10870792     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1087-0792(02)80003-X     Document Type: Conference Paper

References (5)

1. Cluydts R, Peeters K, de Bouyalsky I, Lavoisy J. Comparison of continuous versus intermittent administration of zolpidem in chronic insomnias: A double-blind, randomized pilot study. J Int Med Res 1998; 26: 13-24.
2. Walsh JK, Roth T, Randazzo A, Erman M, Jamieson A, Scharf M, Schweitzer PK, Ware JC. Eight weeks of non-nightly use of zolpidem for primary insomnia. Sleep 2000; 23(8): 1087-1096.
3. Allain H, Arbus L, Schück S and the Zolpidem Study Group. Efficacy and safety of zolpidem administered 'as needed' in primary insomnia. Results of a double-blind, placebo-controlled study. Clin Drug Invest 2001; 21(6): 391-400.
4. Rechtshaffen A, Kales A, eds. A Manual Of Standard Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Los Angeles, CA: UCLA Brain Information Service/Brain Research Institute, 1968.
5. Agnew HW, Webb WB, Williams RL. The first night effect: An EEG study of sleep. Psychophysiology 1996; 2: 262-266.